)
Visual
test
Lipidor
Lipidor (LIPI) investor relations material
Lipidor has been delisted
Lipidor Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2024 earnings summary28 Feb, 2025
Executive summary
Achieved key milestones including successful refinancing and initiation of Phase III clinical trial for psoriasis candidate AKP02G2; first patient recruited in September 2024 and half of patients randomized by January 2025.
Results from the Phase III study are expected in April 2025, with preparations underway for regulatory submission and potential product registration.
Financial highlights
Net sales for Jan–Dec 2024 were 14 tkr (78 tkr year-over-year); H2 2024 net sales were 0 tkr (70 tkr year-over-year).
Operating loss for Jan–Dec 2024 was -14,210 tkr (-15,454 tkr year-over-year); H2 2024 operating loss was -8,576 tkr (-9,573 tkr year-over-year).
Net result for Jan–Dec 2024 was -13,806 tkr (-11,485 tkr year-over-year); H2 2024 net result was -8,517 tkr (-8,239 tkr year-over-year).
Cash flow for Jan–Dec 2024 was 9,587 tkr (-8,299 tkr year-over-year), mainly due to new share issues and asset sales; cash and cash equivalents at year-end were 10,215 tkr (628 tkr prior year).
Equity per share at year-end was 0.01 SEK (-0.32 SEK prior year); equity ratio improved to 66.68% from -330.70%.
Outlook and guidance
Phase III study results for AKP02G2 expected in April 2025; positive results could enable product registration and market launch with partner Menarini/Relife.
Current liquidity is sufficient to complete the ongoing clinical trial, but further funding will be needed for operations beyond the next 12 months.
Additional liquidity may be secured via milestone payments and exercise of TO 2 warrants, contingent on study outcome and share price.
Assess the impact of TO 2 program.
Explain Cerbios's investment agreement.
How does AKP02G2 complement existing products?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Lipidor
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Lipidor AB is a Swedish company based in Stockholm that specializes in developing topical treatments utilizing unique lipid-based formulations. Their primary focus is on creating formulations for psoriasis treatments. The company leverages its proprietary AKVANO technology, which enables the formation of a lipid layer on the skin surface, facilitating effective drug delivery and skin care treatments. Lipidor collaborates with various global pharmaceutical companies, providing formulation concepts and technologies aimed at improving patient quality of life. They manage the entire development process from preclinical stages to clinical trials, often partnering with external companies for manufacturing and clinical studies. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage